Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katharina L. Wiest"'
Publikováno v:
Harm Reduction Journal, Vol 20, Iss 1, Pp 1-13 (2023)
Abstract Background BUP-XR (SUBLOCADE®) is the first buprenorphine extended-release subcutaneous injection approved in the USA for monthly treatment of moderate-to-severe opioid use disorder (OUD). Among patients with OUD, those who inject or use hi
Externí odkaz:
https://doaj.org/article/c923bb74f49c412ea6b467cd77d997da
Autor:
Greenwald, Mark K.1 (AUTHOR) mgreen@med.wayne.edu, Wiest, Katharina L.2 (AUTHOR), Haight, Barbara R.3 (AUTHOR), Laffont, Celine M.3 (AUTHOR), Zhao, Yue3 (AUTHOR)
Publikováno v:
Harm Reduction Journal. 12/2/2023, Vol. 20 Issue 1, p1-13. 13p.
Publikováno v:
Journal of Addiction Medicine; May/Jun2019, Vol. 13 Issue 3, pE1-E42, 42p
Publikováno v:
Clinical Trials Week; 12/18/2023, p1537-1537, 1p
Autor:
Wiest, Katharina L., Colditz, Jason B., Carr, Kathryn, Asphaug, Victoria J., McCarty, Dennis, Pilkonis, Paul A.
Publikováno v:
Journal of Addiction Medicine; Nov/Dec2014, Vol. 8 Issue 6, p407-414, 8p